{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:28:23Z","timestamp":1784028503696,"version":"3.55.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Canadian Institute Heath Grant"},{"name":"Women's Health Research Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Does the occurrence of non-visualized pregnancy loss (NVPL) affect future reproductive outcomes in patients with recurrent pregnancy loss (RPL)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>The number of previous NVPLs is a significant predictor of subsequent live birth in patients with RPL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>The number of preceding miscarriages is a strong indicator for future reproductive outcomes. However, NVPL particularly has been sparsely addressed in previous literature.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>We performed a retrospective cohort study of 1981 patients attending a specialized recurrent pregnancy loss clinic (RPL) from January 2012 to March 2021. A total of 1859 patients met the inclusion criteria of the study and were included in the analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Patients with a history of RPL, defined as \u22652 pregnancy losses before 20\u2009weeks gestation, who attended a specialized RPL clinic in a tertiary care center were included. Patients\u2019 evaluation included parental karyotyping, antiphospholipid antibodies screening, uterine cavity assessment with hysterosalpingography (HSG) or hysteroscopy, maternal thyroid stimulating hormone (TSH) testing, and serum hemoglobin A1C testing. Other investigations were performed only when indicated such as testing for inherited thrombophilias, serum prolactin, oral glucose tolerance test, and endometrial biopsy. Patients were divided into three groups; patients who experienced NVPLs only (pure NVPLs group), patients with only visualized pregnancy losses (pure VPLs group), and patients with history of both NVPLs and VPLs (mixed group). Statistical analysis was performed using Wilcoxon rank-sum tests for continuous variables and Fisher\u2019s exact tests for categorical variables. Significance was detected when P values &amp;lt;0.05. A logistic regression model was used to determine the impact of NVPLs and VPLs numbers on any live birth subsequent to the initial RPL clinic visit.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>The prevalence of patients with pure NVPLs, pure VPLs, and mixed losses was 14.7% (274\/1859), 31.8% (591\/1859), and 53.5% (994\/1859), respectively. The prevalence of acquired and congenital uterine anomalies diagnosed by HSG or hysteroscopy was significantly different between pure NVPLs, pure VPLs, and mixed groups (16.8% versus 23.7% versus. 20.7%, respectively P\u2009=\u20090.05). There were no significant differences in the results of other RPL investigations or baseline demographics between the three groups. A logistic regression model controlling for maternal age at the initial RPL clinic visit and the follow-up duration showed that the numbers of NVPLs (odds ratio (OR): 0.77, CI: 0.68\u20130.88) and VPLs (OR: 0.75, CI: 0.64\u20130.86) are strong predictors for subsequent live births after the initial RPL clinic visit (P\u2009&amp;lt;\u20090.001). The odds of having a live birth decreased by 23% and 25% with each additional NVPL and VPL, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>This study may be limited by its retrospective design. Some of our data, including home pregnancy tests and obstetric history, are based on patient self-reporting, which could have overstated the true prevalence of NVPLs. Another limitation is the lack of available live birth data for all patients at the time of the analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>To our knowledge, this is the first study to examine and analyze the reproductive outcomes of patients with pure NVPLs in a substantial cohort of patients with RPL. NVPLs seem to affect future live births the same way as clinical miscarriages, which supports their inclusion in RPL definitions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This study was supported in part by Canadian Institute Heath Grant (CIHR): Reference Number\/W11-179912 and Women's Health Research Institute (WHRI), Vancouver, BC, Canada. M.A.B: Research grants from Canadian Institute for Health Research (CIHR) and Ferring Pharmaceutical. M.A.B. is on the advisory board for AbbVie and Baxter.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/dead040","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T19:29:09Z","timestamp":1678217349000},"page":"830-839","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence, causes, and impact of non-visualized pregnancy losses in a recurrent pregnancy loss population"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3454-8555","authenticated-orcid":false,"given":"Mohamed A","family":"Bedaiwy","sequence":"first","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, The University of British Columbia , Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-2313","authenticated-orcid":false,"given":"Bahi","family":"Fayek","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, The University of British Columbia , Vancouver, BC, Canada"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Menoufia University , Menoufia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2786-1794","authenticated-orcid":false,"given":"Emily C","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, The University of British Columbia , Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3202-5777","authenticated-orcid":false,"given":"Mahmoud S","family":"Iews","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, The University of British Columbia , Vancouver, BC, Canada"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, South Valley University , Qena, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1831-0202","authenticated-orcid":false,"given":"Mohamed","family":"Elgendi","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, The University of British Columbia , Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-4567","authenticated-orcid":false,"given":"Amr O","family":"Abdelkareem","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, The University of British Columbia , Vancouver, BC, Canada"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Sohag University , Sohag, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H","family":"Abdellah","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, The University of British Columbia , Vancouver, BC, Canada"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, South Valley University , Qena, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7350-0434","authenticated-orcid":false,"given":"Yang Doris","family":"Liu","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Institute , Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0340-3414","authenticated-orcid":false,"given":"Adrian","family":"Jones","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Institute , Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Mayer","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Institute , Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-3034","authenticated-orcid":false,"given":"Faten F","family":"Abdel Hafez","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, The University of British Columbia , Vancouver, BC, Canada"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University , Assiut, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"2023050207194705000_dead040-B1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.fertnstert.2006.08.098","article-title":"Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment","volume":"87","author":"Bellver","year":"2007","journal-title":"Fertil Steril"},{"key":"2023050207194705000_dead040-B2","first-page":"245","article-title":"Production of human chorionic gonadotropin during the normal menstrual cycle","volume":"54","author":"Cole","year":"2009","journal-title":"J Reprod Med"},{"key":"2023050207194705000_dead040-B3","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/humrep\/dew169","article-title":"Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?","volume":"31","author":"Egerup","year":"2016","journal-title":"Hum Reprod"},{"key":"2023050207194705000_dead040-B4","doi-asserted-by":"crossref","first-page":"hoy004","DOI":"10.1093\/hropen\/hoy004","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"ESHRE Guideline Group on RPL","year":"2018","journal-title":"Hum Reprod Open"},{"key":"2023050207194705000_dead040-B5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1515\/jpm-2016-0411","article-title":"Pregnancy outcomes among patients with recurrent pregnancy loss and uterine anatomic abnormalities","volume":"46","author":"Gabbai","year":"2018","journal-title":"J Perinat Med"},{"key":"2023050207194705000_dead040-B6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/humrep\/deu052","article-title":"Time to conception and time to live birth in women with unexplained recurrent miscarriage","volume":"29","author":"Kaandorp","year":"2014","journal-title":"Hum Reprod"},{"key":"2023050207194705000_dead040-B7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00404-017-4532-4","article-title":"Fertility after recurrent miscarriages: results of an observational cohort study","volume":"297","author":"Kling","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"2023050207194705000_dead040-B8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/humrep\/dey362","article-title":"Recurrent pregnancy loss: couples\u2019 perspectives on their need for treatment, support and follow up","volume":"34","author":"Koert","year":"2019","journal-title":"Hum Reprod"},{"key":"2023050207194705000_dead040-B9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humrep\/deu299","article-title":"Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group","volume":"30","author":"Kolte","year":"2015","journal-title":"Hum Reprod"},{"key":"2023050207194705000_dead040-B10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/humrep\/deu042","article-title":"Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage","volume":"29","author":"Kolte","year":"2014","journal-title":"Hum Reprod"},{"key":"2023050207194705000_dead040-B11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1741-7015-11-154","article-title":"New insights into mechanisms behind miscarriage","volume":"11","author":"Larsen","year":"2013","journal-title":"BMC Med"},{"key":"2023050207194705000_dead040-B12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/09513590.2014.994601","article-title":"History of biochemical pregnancy was associated with the subsequent reproductive failure among women with recurrent spontaneous abortion","volume":"31","author":"Maesawa","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2023050207194705000_dead040-B13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/15513815.2018.1455775","article-title":"Early pregnancy losses: review of nomenclature, histopathology, and possible etiologies","volume":"37","author":"Pinar","year":"2018","journal-title":"Fetal Pediatr Pathol"},{"key":"2023050207194705000_dead040-B14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","journal-title":"Fertil Steril"},{"key":"2023050207194705000_dead040-B15","first-page":"1","article-title":"The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage","volume":"17","author":"Regan","year":"2011","journal-title":"RCOG Green Top Guideline"},{"key":"2023050207194705000_dead040-B16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0015-0282(99)00408-2","article-title":"Early pregnancy losses in in vitro fertilization and oocyte donation","volume":"72","author":"Sim\u00f3n","year":"1999","journal-title":"Fertil Steril"},{"key":"2023050207194705000_dead040-B17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1289\/ehp.877529","article-title":"The use of biochemical assays in epidemiologic studies of reproduction","volume":"75","author":"Wilcox","year":"1987","journal-title":"Environ Health Perspect"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/5\/830\/50128094\/dead040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/5\/830\/50128094\/dead040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T07:20:50Z","timestamp":1683012050000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/38\/5\/830\/7070686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3,6]]},"published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dead040","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2023,3,6]]}}}